{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:11:32Z","timestamp":1777551092078,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":2412,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1038\/mt.2009.279","type":"journal-article","created":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T14:59:44Z","timestamp":1259679584000},"page":"609-616","source":"Crossref","is-referenced-by-count":27,"title":["Induction of Shock After Intravenous Injection of Adenovirus Vectors: A Critical Role for Platelet-activating Factor"],"prefix":"10.1016","volume":"18","author":[{"given":"Zhili","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey S.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew P.","family":"Byrnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2009.279_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2007.10.005","article-title":"Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications","volume":"132","author":"Hartman","year":"2008","journal-title":"Virus Res"},{"key":"10.1038\/mt.2009.279_bib2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/toxsci\/65.2.266","article-title":"Rodent nonclinical safety evaluation studies of SCH 58500, an adenoviral vector for the p53 gene","volume":"65","author":"Morrissey","year":"2002","journal-title":"Toxicol Sci"},{"key":"10.1038\/mt.2009.279_bib3","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ymthe.2004.03.010","article-title":"Severe pulmonary pathology after intravenous administration of vectors in cirrhotic rats","volume":"9","author":"Smith","year":"2004","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2009.279_bib4","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.gt.3302149","article-title":"Unexpected pulmonary uptake of adenovirus vectors in animals with chronic liver disease","volume":"11","author":"Smith","year":"2004","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2009.279_bib5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.vascn.2008.07.003","article-title":"Influence of method of systemic administration of adenovirus on virus-mediated toxicity: focus on mortality, virus distribution, and drug metabolism","volume":"58","author":"Boquet","year":"2008","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1038\/mt.2009.279_bib6","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1089\/104303403322542275","article-title":"A hemodynamic response to intravenous adenovirus vector particles is caused by systemic Kupffer cell-mediated activation of endothelial cells","volume":"14","author":"Schiedner","year":"2003","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2009.279_bib7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ymthe.2005.03.007","article-title":"Characterization of hemodynamic events following intravascular infusion of recombinant adenovirus reveals possible solutions for mitigating cardiovascular responses","volume":"12","author":"Machemer","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2009.279_bib8","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/mt.2008.280","article-title":"Cancer-induced expansion and activation of CD11b+ Gr-1+ cells predispose mice to adenoviral-triggered anaphylactoid-type reactions","volume":"17","author":"Pande","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2009.279_bib9","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/sj.cgt.7700539","article-title":"Intravascular adenoviral agents in cancer patients: lessons from clinical trials","volume":"9","author":"Reid","year":"2002","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/mt.2009.279_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/205199b0","article-title":"Mechanism of anaphylactic death in the mouse","volume":"205","author":"Munoz","year":"1965","journal-title":"Nature"},{"key":"10.1038\/mt.2009.279_bib11","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/toxsci\/65.2.256","article-title":"Porcine toxicology studies of SCH 58500, an adenoviral vector for the p53 gene","volume":"65","author":"Morrissey","year":"2002","journal-title":"Toxicol Sci"},{"key":"10.1038\/mt.2009.279_bib12","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1067\/mai.2002.123302","article-title":"Pathways of anaphylaxis in the mouse","volume":"109","author":"Strait","year":"2002","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl","key":"10.1038\/mt.2009.279_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0031-6989(86)90051-2","article-title":"Evidence of a role for PAF-acether in the pathophysiology of the shock state","volume":"18","author":"Sanchez Crespo","year":"1986","journal-title":"Pharmacol Res Commun"},{"key":"10.1038\/mt.2009.279_bib14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF01980894","article-title":"Hypotensive action of IgG preparations containing aggregates is suppressed by PAF-receptor antagonist BN 52021 and by gadolinium chloride (an agent blocking Kupffer cell function)","volume":"32","author":"Jenei","year":"1991","journal-title":"Agents Actions"},{"key":"10.1038\/mt.2009.279_bib15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0014-2999(00)00632-4","article-title":"Obligatory role of nitric oxide in platelet-activating factor-induced microvascular leakage","volume":"404","author":"Klabunde","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1038\/mt.2009.279_bib16","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1152\/physrev.2000.80.4.1669","article-title":"Role of platelet-activating factor in cardiovascular pathophysiology","volume":"80","author":"Montrucchio","year":"2000","journal-title":"Physiol Rev"},{"key":"10.1038\/mt.2009.279_bib17","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/714037693","article-title":"Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes","volume":"40","author":"Stafforini","year":"2003","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1038\/mt.2009.279_bib18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJMoa070030","article-title":"Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis","volume":"358","author":"Vadas","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2009.279_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0014-2999(97)00109-X","article-title":"Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist","volume":"325","author":"Albert","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1038\/mt.2009.279_bib20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0022-3565(25)39063-4","article-title":"CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo","volume":"242","author":"Terashita","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1038\/mt.2009.279_bib21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/319054a0","article-title":"Potent ulcerogenic actions of platelet-activating factor on the stomach","volume":"319","author":"Rosam","year":"1986","journal-title":"Nature"},{"key":"10.1038\/mt.2009.279_bib22","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1476-5381.1994.tb13197.x","article-title":"Study of the effector mechanism involved in the production of haemorrhagic necrosis of the small intestine in rat passive anaphylaxis","volume":"112","author":"Pell\u00f3n","year":"1994","journal-title":"Br J Pharmacol"},{"key":"10.1038\/mt.2009.279_bib23","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.3181\/00379727-133-34695","article-title":"Simple method for quantitation of enhanced vascular permeability","volume":"133","author":"Udaka","year":"1970","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1038\/mt.2009.279_bib24","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0090-6980(88)90009-3","article-title":"PAF increases vascular permeability in selected tissues: effect of BN-52021 and L-655,240","volume":"36","author":"Sirois","year":"1988","journal-title":"Prostaglandins"},{"key":"10.1038\/mt.2009.279_bib25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ymthe.2005.08.007","article-title":"Rapid Kupffer cell death after intravenous injection of adenovirus vectors","volume":"13","author":"Manickan","year":"2006","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2009.279_bib26","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1042\/bj2570823","article-title":"Biosynthesis of platelet-activating factor by cultured rat Kupffer cells stimulated with calcium ionophore A23187","volume":"257","author":"Chao","year":"1989","journal-title":"Biochem J"},{"key":"10.1038\/mt.2009.279_bib27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/11024150260102816","article-title":"Lexipafant and acute pancreatitis: a critical appraisal of the clinical trials","volume":"168","author":"Abu-Zidan","year":"2002","journal-title":"Eur J Surg"},{"key":"10.1038\/mt.2009.279_bib28","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0090-6980(85)90018-8","article-title":"Pharmacological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse","volume":"30","author":"Young","year":"1985","journal-title":"Prostaglandins"},{"key":"10.1038\/mt.2009.279_bib29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1476-5381.1986.tb10275.x","article-title":"Effects of inhibitors of arachidonic acid metabolism on Paf-induced gastric mucosal necrosis and haemoconcentration","volume":"89","author":"Wallace","year":"1986","journal-title":"Br J Pharmacol"},{"key":"10.1038\/mt.2009.279_bib30","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1089\/hum.2005.16.1439","article-title":"Elimination of innate immune responses and liver inflammation by PEGylation of adenoviral vectors and methylprednisolone","volume":"16","author":"De Geest","year":"2005","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2009.279_bib31","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/mt.2008.297","article-title":"Transient pretreatment with glucocorticoid ablates innate toxicity of systemically delivered adenoviral vectors without reducing efficacy","volume":"17","author":"Seregin","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2009.279_bib32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/10430340460732445","article-title":"Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates","volume":"15","author":"Brunetti-Pierri","year":"2004","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2009.279_bib33","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/sj.mt.6300319","article-title":"Comparison of adenoviruses from species B, C, E, and F after intravenous delivery","volume":"15","author":"Stone","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2009.279_bib34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.virol.2008.01.017","article-title":"Replication-attenuated Human Adenoviral Type 4 vectors elicit capsid dependent enhanced innate immune responses that are partially dependent upon interactions with the complement system","volume":"374","author":"Hartman","year":"2008","journal-title":"Virology"},{"key":"10.1038\/mt.2009.279_bib35","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/gt.2008.18","article-title":"Wild-type adenoviruses from groups A-F evoke unique innate immune responses, of which HAd3 and SAd23 are partially complement dependent","volume":"15","author":"Appledorn","year":"2008","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2009.279_bib36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/sj.gt.3301647","article-title":"Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion","volume":"9","author":"Garcia-Ba\u00f1uelos","year":"2002","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2009.279_bib37","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1073\/pnas.0500930102","article-title":"Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector","volume":"102","author":"Toietta","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2009.279_bib38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archsurg.1988.01400270061009","article-title":"Splenectomy alters Kupffer cell response to endotoxin","volume":"123","author":"Billiar","year":"1988","journal-title":"Arch Surg"},{"key":"10.1038\/mt.2009.279_bib39","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0168-8278(99)80219-0","article-title":"Splenectomy attenuates superoxide anion release into the hepatic sinusoids after lipopolysaccharide challenge","volume":"31","author":"Mizukami","year":"1999","journal-title":"J Hepatol"},{"key":"10.1038\/mt.2009.279_bib40","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0162-3109(82)90019-4","article-title":"Vascular actions of synthetic PAF-acether (a synthetic platelet-activating factor) in the rat: evidence for a platelet independent mechanism","volume":"4","author":"S\u00e1nchez-Crespo","year":"1982","journal-title":"Immunopharmacology"},{"key":"10.1038\/mt.2009.279_bib41","doi-asserted-by":"crossref","first-page":"14138","DOI":"10.1073\/pnas.0906467106","article-title":"Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection","volume":"106","author":"Souza","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2009.279_bib42","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0049-3848(82)90234-1","article-title":"Species specificity of the platelet responses to 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine","volume":"25","author":"Namm","year":"1982","journal-title":"Thromb Res"},{"key":"10.1038\/mt.2009.279_bib43","first-page":"303","article-title":"Acetyl glyceryl ether phosphorylcholine. Intravascular alterations following intravenous infusion into the baboon","volume":"45","author":"McManus","year":"1981","journal-title":"Lab Invest"},{"key":"10.1038\/mt.2009.279_bib44","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0049-3848(86)90344-0","article-title":"Platelet activating factor (PAF) involvement in endotoxin-induced thrombocytopenia in rabbits: studies with FR-900452, a specific inhibitor of PAF","volume":"42","author":"Okamoto","year":"1986","journal-title":"Thromb Res"},{"key":"10.1038\/mt.2009.279_bib45","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/372179a0","article-title":"Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene","volume":"372","author":"Chen","year":"1994","journal-title":"Nature"},{"key":"10.1038\/mt.2009.279_bib46","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jviromet.2007.08.009","article-title":"A quantitative assay for measuring clearance of adenovirus vectors by Kupffer cells","volume":"147","author":"Smith","year":"2008","journal-title":"J Virol Methods"},{"key":"10.1038\/mt.2009.279_bib47","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/ajh.2008.301","article-title":"Validation of volume-pressure recording tail-cuff blood pressure measurements","volume":"21","author":"Feng","year":"2008","journal-title":"Am J Hypertens"},{"key":"10.1038\/mt.2009.279_bib48","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1172\/JCI112980","article-title":"Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats","volume":"79","author":"Chang","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2009.279_bib49","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/sj.bjp.0705296","article-title":"Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment","volume":"139","author":"Souza","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1038\/mt.2009.279_bib50","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0022-1759(94)90012-4","article-title":"Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications","volume":"174","author":"Van Rooijen","year":"1994","journal-title":"J Immunol Methods"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616323115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616323115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T15:00:43Z","timestamp":1739458843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616323115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S1525001616323115"],"URL":"https:\/\/doi.org\/10.1038\/mt.2009.279","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}